Haematological Malignancy Clinical Trial
Official title:
APALLO : Post Allogeneic Stem Cell Transplantation Adapted Physical Activity for Patient With Hematological Malignancies
It is a study about adaptated physical activity for patients receiving a stem cell transplantation. They will benefit of 6 adaptated individuals lessons at home between 1 month and 3 months after stem cell transplantation. The study's goal is to observe if adaptated activity has an positive impact on weight loss and on life quality.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03978312 -
Nutrition Health Literacy of Cancer Patients and Their Support Networks.
|
||
| Recruiting |
NCT03750994 -
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology
|
||
| Recruiting |
NCT04397705 -
Remote Monitoring of Cancer Patients With Suspected Covid-19
|
Phase 1 | |
| Recruiting |
NCT05678621 -
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05203809 -
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies
|
||
| Active, not recruiting |
NCT03146468 -
Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation
|
Phase 2 | |
| Recruiting |
NCT05298930 -
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
|
N/A | |
| Not yet recruiting |
NCT06395220 -
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
|
||
| Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04673305 -
Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies
|
N/A | |
| Recruiting |
NCT05768178 -
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05722886 -
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
|
Phase 2/Phase 3 | |
| Completed |
NCT03855969 -
Central Venous Access Device Removal in Cancer Patients
|
||
| Recruiting |
NCT04174053 -
Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care Units
|
N/A | |
| Recruiting |
NCT05770544 -
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers.
|
Phase 2/Phase 3 | |
| Completed |
NCT04236063 -
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
|
||
| Recruiting |
NCT05695638 -
Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment
|
||
| Recruiting |
NCT04298892 -
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
|
||
| Withdrawn |
NCT03688789 -
Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology
|
N/A | |
| Withdrawn |
NCT04331483 -
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
|
N/A |